Medivolve Inc (MEDV.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 289 | 256 | 183 | 194 | 1,433 |
| Cost of Goods | 26 | 39 | 46 | -199 | 769 |
| Gross Profit | 262 | 217 | 137 | 393 | 664 |
| Operating Expenses | 730 | 764 | 1,293 | 1,790 | 2,323 |
| Operating Income | -467 | -548 | -1,157 | -1,398 | -1,659 |
| Interest Expense | 6 | N/A | 78 | 116 | 65 |
| Other Income | -185 | 18 | 129 | -170 | -1,165 |
| Pre-tax Income | -659 | -530 | -1,106 | -1,684 | -2,889 |
| Income Tax | N/A | N/A | N/A | 0 | 23 |
| Net Income Continuous | -659 | -530 | -1,106 | -1,684 | -2,912 |
| Net Income Discontinuous | -344 | -7,898 | -2,537 | N/A | N/A |
| Minority Interests | 72 | 54 | 135 | 20 | N/A |
| Net Income | $-932 | $-8,374 | $-3,508 | $-1,663 | $-2,912 |
| EPS Basic Total Ops | N/A | N/A | -0.13 | -0.06 | -0.11 |
| EPS Basic Continuous Ops | N/A | N/A | -0.04 | -0.06 | -0.11 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.09 | N/A | N/A |
| EPS Diluted Total Ops | N/A | N/A | -0.13 | -0.06 | -0.11 |
| EPS Diluted Continuous Ops | N/A | N/A | -0.04 | -0.06 | -0.11 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.09 | N/A | N/A |
| EBITDA(a) | $-602 | $-155 | $-977 | $-1,428 | $-2,665 |